Defensins in the biological fluids of children suffer from COVID-19: peculiarities of identification and interpretation
DOI:
https://doi.org/10.15574/PP.2024.98.92Keywords:
children, SARS-CoV-2 virus, defensins, blood serum, lung expirateAbstract
The SARS-CoV-2 novel coronavirus caused a global pandemic and mortality in the human population. Defensins are antimicrobial peptides that exert pro-inflammatory and anti-inflammatory activity and can inhibit viral infection by modulating of immune cells functions.
Aim - to study the content of defensins in biological fluids - blood serum, lung expirate, to establish their diagnostic and prognostic significance in relation to the course of the infectious process.
Materials and methods. 223 children of various ages were examined. The study group consisted of 124 patients (1st group) who suffered from confirmed SARS-CoV-2 infection. The control group (2nd group) included 99 children who were not diagnosed with COVID-19. The level of defensins in serum and pulmonary was determined in sick children. For calculations and statistical analysis, a statistical package was used using methods of descriptive statistics and clinical epidemiology. The population analysis evaluated attributive (AR) and relative risks (VR) with calculation of confidence intervals (95% CI) for VR and odds ratio (OR). Statistically significant differences are accepted when the Student's test is less than 0.05 (P<0.05).
Results. Determining the level of defensins in the serum of the study groups, no statistical differences were found. However, when studying the amount of peptides in the pulmonary expirate, it was found that in patients of 1st group during the first week of the disease, the level of defensins was higher compared to of 2nd group. The amount of polypeptides in the exhaled air condensate of patients with a complicated course of the disease was more than 300.0 pg/ml in children of 1st group, especially girls, comparing with the control group: AR - 33%, VR - 1.86 (95% CI 1.19-2.88), OR - 4.0 (95% CI 2.14-7.49). AR=33%, VR = 1.86 (95% CI 1.19-2.88), OR = 4.0 (95% CI 2.14-7.49).
Conclusions. The condensate of pulmonary expirate infected with the SARS-CoV2 virus of children contains significantly more defensins. The highest concentrations are associated with the severity of respiratory organ damage (OR=4.0) and belonging to the female sex (P<0.05). Determination of the concentration of antimicrobial peptides in the pulmonary expirate in inflammatory processes of the respiratory system, in particular in COVID-19, can serve as a diagnostic marker.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. Informed consent of parents and children was obtained for research.
No conflict of interests was declared by the authors.
References
Abdeen S, Bdeir K, Abu-Fanne R, Maraga E, Higazi M, Khurram N et al. (2021, Jul). Alpha-defensins: risk factor for thrombosis in COVID-19 infection. Br J Haematol. 194(1): 44-52. Epub 2021 May 30. https://doi.org/10.1111/bjh.17503; PMid:34053084 PMCid:PMC8239944
Abu-Fanne R, Stepanova V, Litvinov RI, Abdeen S, Bdeir K, Higazi M et al. (2019, Jan 31). Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability. Blood. 133(5): 481-493. Epub 2018 Nov 15. https://doi.org/10.1182/blood-2018-07-861237; PMid:30442678 PMCid:PMC6356988
American Thoracic Society; European Respiratory Society. (2005, Apr 15). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 171(8): 912-930. https://doi.org/10.1164/rccm.200406-710ST; PMid:15817806
Cui X, Zhang T, Zheng J, Zhang J, Si P, Xu Y et al. (2020, Sep). Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients. J Med Virol. 92(9): 1501-1510. Epub 2020 Jun 2. https://doi.org/10.1002/jmv.26023; PMid:32418216 PMCid:PMC7276885
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. (2020, Jun). Epidemiology of COVID-19 Among Children in China. Pediatrics. 145(6): e20200702. Epub 2020 Mar 16. https://doi.org/10.1542/peds.2020-0702; PMid:32179660
Hashemi SA, Golab Behbahan NG, Bahrani S, Mousavi SM, Gholami A, Ramakrishna S et al. (2021, Jan 1). Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/non-biological media. Biosens Bioelectron. 171: 112731. Epub 2020 Oct 15. https://doi.org/10.1016/j.bios.2020.112731; PMid:33075725 PMCid:PMC7558249
Hazlett L, Wu M. (2011, Jan). Defensins in innate immunity. Cell Tissue Res. 343(1): 175-88. Epub 2010 Aug 21. https://doi.org/10.1007/s00441-010-1022-4; PMid:20730446
Greenberg RS, Daniels SR, Flanders WD et al. (2004). Medical Epidemiology. 4th Edition. Norwalk, CT: Appleton & Lange: 196.
Murillo-Zamora E, Aguilar-Sollano F, Delgado-Enciso I, Hernandez-Suarez CM. (2020, Dec). Predictors of laboratory-positive COVID-19 in children and teenagers. Public Health. 189: 153-157. Epub 2020 Oct 23. https://doi.org/10.1016/j.puhe.2020.10.012; PMid:33246302 PMCid:PMC7584439
Murillo-Zamora E, Trujillo X, Huerta M, Ríos-Silva M, Mendoza-Cano O. (2020, Sep 16). Male gender and kidney illness are associated with an increased risk of severe laboratory-confirmed coronavirus disease. BMC Infect Dis. 20(1): 674. https://doi.org/10.1186/s12879-020-05408-6; PMid:32938419 PMCid:PMC7493056
Öztürk A, Kurt-Bayrakdar S, Avci B. (2021, May). Comparison of gingival crevicular fluid and serum human beta-defensin-2 levels between periodontal health and disease. Oral Dis. 27(4): 993-1000. Epub 2020 Sep 21. https://doi.org/10.1111/odi.13597; PMid:32772492
Shrivastava S, Chelluboina S, Jedge P, Doke P, Palkar S et al. (2021, Oct 21). Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients. Front Cell Infect Microbiol. 11: 751232. https://doi.org/10.3389/fcimb.2021.751232; PMid:34746027 PMCid:PMC8566808
Tecle T, Tripathi S, Hartshorn KL. (2010, Jun). Review: Defensins and cathelicidins in lung immunity. Innate Immun. 16(3): 151-159. Epub 2010 Apr 23. https://doi.org/10.1177/1753425910365734; PMid:20418263
Tokatli MR, Sisti LG, Marziali E, Nachira L, Rossi MF, Amantea C et al. (2022, Mar 7). Hormones and Sex-Specific Medicine in Human Physiopathology. Biomolecules. 12(3): 413. https://doi.org/10.3390/biom12030413; PMid:35327605 PMCid:PMC8946266
Wang G. (2014, May 13). Human antimicrobial peptides and proteins. Pharmaceuticals (Basel). 7(5): 545-594. https://doi.org/10.3390/ph7050545; PMid:24828484 PMCid:PMC4035769
White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb R, Sapsford D et al. (2020, Aug). Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 50(2): 287-291. Erratum in: J Thromb Thrombolysis. 2020 Jun 22. https://doi.org/10.1007/s11239-020-02145-0; PMid:32445064 PMCid:PMC7242778
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. (2020, Mar 28). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 395(10229): 1054-1062. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28. 395(10229): 1038. Erratum in: Lancet. 2020 Mar 28. 395(10229): 1038. PMID: 32171076. https://doi.org/10.1016/S0140-6736(20)30566-3; PMid:32171076
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.